ProQuest www.csa.com
 
 
RefWorks
  
Discovery Guides Areas
>
>
>
>
>
 
  
e-Journal

 

Tracking down the Footprints of Bipolar Disorder
(Released June 2005)

 
  by Jennifer A. Phillips  

Review

Key Citations

Web Sites

Glossary

Conferences

Editor
 
Key Citations Short Format Full Format

  1. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation
    Am.J.Med.Genet.B., Vol. 127B, No. 1, pp. 51-59. , 2004.

  2. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders
    Am.J.Med.Genet.B., Vol. 132B, No. 1, pp. 90-95. , 2005.

  3. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders
    Am.J.Med.Genet.B., Vol. 132B, No. 1, pp. 90-95. , 2005.

  4. A linkage study between the GABAA beta2 and GABAA gamma2 subunit genes and major psychoses
    CNS spectrums, Vol. 10, No. 1, pp. 57-61. Jan, 2005.

  5. Schema-focused cognitive therapy for bipolar disorder: Reducing vulnerability to relapse through attitudinal change
    Australian & New Zealand Journal of Psychiatry, Vol. 37, No. 1, pp. 41-48. Feb, 2003.

  6. Ticks and Lyme disease
    Advances in Parasitology 36 1995: 343-405, Vol. , No. , pp. . , 1995.

  7. Are measures of hypomanic personality, impulsive nonconformity and rigidity predictors of bipolar symptoms?
    The British journal of clinical psychology / the British Psychological Society, Vol. 44, No. Pt 1, pp. 15-27. Mar, 2005.

  8. Lyme disease: Review from a Canadian perspective
    Can.Fam.Physician, Vol. 38, No. , pp. 1426-1432. , 1992.

  9. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system
    The American journal of clinical nutrition, Vol. 80, No. 6 Suppl, pp. 1717S-20S. Dec, 2004.

  10. Is there a relationship between Wolfram syndrome carrier status and suicide?
    American journal of medical genetics, Vol. 114, No. 3, pp. 343-346. Apr 8, 2002.

  11. Screening for bipolar disorder in a primary care practice
    JAMA : the journal of the American Medical Association, Vol. 293, No. 8, pp. 956-963. Feb 23, 2005.

  12. Polymorphisms in the Trace Amine Receptor 4 (TRAR4) Gene on Chromosome 6q23.2 Are Associated with Susceptibility to Schizophrenia
    Am.J.Hum.Genet., Vol. 75, No. 4, pp. 624-638. Oct, 2004.

  13. Molecular diagnosis of Lyme disease: review and meta-analysis
    Molecular diagnosis : a.journal devoted to.the understanding of human disease through the clinical application of molecular biology, Vol. 6, No. 1, pp. 1-11. Mar, 2001.

  14. Good diagnoses require good diagnosticians: collecting and integrating the data
    American journal of medical genetics, Vol. 105, No. 1, pp. 48-49. Jan 8, 2001.

  15. Good diagnoses require good diagnosticians: collecting and integrating the data
    American journal of medical genetics, Vol. 105, No. 1, pp. 48-49. Jan 8, 2001.

  16. Bipolar disorder: I. Temperament and character
    Journal of affective disorders, Vol. 82, No. 1, pp. 131-134. Oct 1, 2004.

  17. A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorder
    Am.J.Med.Genet.B., Vol. 133B, No. 1, pp. 25-30. , 2005.

  18. Neurocognitive function in unaffected firstdegree relatives of patients with bipolar disorder: A preliminary report
    Bipolar Disord., Vol. 6, No. 4, pp. 319-322. Aug, 2004.

  19. Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate
    J.Neurosci., Vol. 24, No. 18, pp. 4412-4420. 5 May, 2004.

  20. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog
    Sleep, Vol. 26, No. 8, pp. 953-959. Dec 15, 2003.

  21. A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases
    Neurosci.Lett., Vol. 277, No. 2, pp. 123-126. Dec, 1999.

  22. Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Am.J.Psychiatry, Vol. 161, No. 2, pp. 217-222. Feb, 2004.

  23. Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Am.J.Psychiatry, Vol. 161, No. 2, pp. 217-222. Feb, 2004.

  24. Linkage Disequilibrium of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism in Children With a Prepubertal and Early Adolescent Bipolar Disorder Phenotype
    Am.J.Psychiatry, Vol. 161, No. 9, pp. 1698-1700. 1 Sep, 2004.

  25. MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed
    Mol.Psychiatry, Vol. 10, No. 2, pp. 147-159. Feb, 2005.

  26. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders
    Mol.Psychiatry, Vol. 10, No. 2, pp. 160-184. Feb, 2005.

  27. Hippocampal volumetrics differentiate patients with temporal lobe epilepsy and extratemporal lobe epilepsy
    Archives of neurology, Vol. 52, No. 8, pp. 819-824. Aug, 1995.

  28. Depression with versus without manic features in rapid-cycling bipolar disorder
    The Journal of nervous and mental disease, Vol. 192, No. 9, pp. 602-606. Sep, 2004.

  29. Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: evidence, limitations, and implications
    Current psychiatry.reports, Vol. 5, No. 6, pp. 469-476. Dec, 2003.

  30. Critical role of brain-derived neurotrophic factor in mood disorders
    Brain Res.Rev., Vol. 45, No. 2, pp. 104-114. May, 2004.

  31. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicity
    Neuropharmacology, Vol. 43, No. 7, pp. 1173-1179. Dec, 2002.

  32. Identification of an cysteine-to-arginine substitution caused by a single nucleotide polymorphism in the canine monoamine oxidase B gene
    The Journal of veterinary medical science / the Japanese Society of Veterinary Science, Vol. 67, No. 2, pp. 199-201. Feb, 2005.

  33. Disrupted in Schizophrenia 1 (DISC1): Association with Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder
    Am.J.Hum.Genet., Vol. 75, No. 5, pp. 862-872. Nov, 2004.

  34. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior
    Neuropsychobiology, Vol. 48, No. 4, pp. 186-189. , 2003.

  35. MRI-based hippocampal volumetrics: data acquisition, normal ranges, and optimal protocol
    Magnetic resonance imaging, Vol. 13, No. 8, pp. 1057-1064. , 1995.

  36. Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease
    Neurology, Vol. 63, No. 7 Suppl 2, pp. S13-22. Oct 12, 2004.

  37. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats
    The Journal of physiology, Vol. 548, No. Pt 2, pp. 557-62. Epub: 2003 Mar 07. Apr 15, 2003.

  38. Drug-induced decrease of protein kinase a activity reveals alteration in BDNF expression of bipolar affective disorder
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 29, No. 4, pp. 805-812. Apr, 2004.

  39. Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei
    Brain research, Vol. 1043, No. 1-2, pp. 57-64. May 10, 2005.

  40. Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder
    American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, Vol. 135, No. 1, pp. 47-49. May 5, 2005.

  41. Memory and verbal learning functions in twins with bipolar-I disorder, and the role of information-processing speed
    Psychological medicine, Vol. 35, No. 2, pp. 205-215. Feb, 2005.

  42. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells
    Science (Wash.), Vol. 289, No. 5485, pp. 1754-1757. 8 Sep, 2000.

  43. The Darwinian concept of stress: Benefits of allostasis and costs of allostatic load and the trade-offs in health and disease
    Neuroscience & Biobehavioral Reviews.Special Individual differences in behavior and physiology: causes and consequences, Vol. 29, No. 1, pp. 3-38. Feb, 2005.

  44. Perspectives on MAO-B in Aging and Neurological Disease: Where Do We Go From Here?
    Mol.Neurobiol., Vol. 30, No. 1, pp. 077-090. Aug, 2004.

  45. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study
    Biological psychiatry., Vol. 56, No. 5, pp. 376-378. Sep 1, 2004.

  46. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study
    Biological psychiatry., Vol. 56, No. 5, pp. 376-378. Sep 1, 2004.

  47. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan
    BMC medical genetics [electronic.resource], Vol. 6, No. 1, pp. 14. Epub: 2005 Mar 31. Mar 31, 2005.

  48. Bipolar disorder: A cognitive therapy approach
    Behaviour Research & Therapy, Vol. 41, No. 5, pp. 629. May, 2003.

  49. Quantitative MRI in outpatient childhood epilepsy
    Epilepsia, Vol. 38, No. 12, pp. 1289-1293. Dec, 1997.

  50. MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake
    Genes, brain, and behavior, Vol. 3, No. 4, pp. 216-227. Aug, 2004.

  51. Bipolar disorder and substance abuse
    Biol.Psychiatry, Vol. 56, No. 10, pp. 738-748. 15 Nov, 2004.

  52. Immunologic variables in acute mania of bipolar disorder
    Journal of neuroimmunology, Vol. 150, No. 1-2, pp. 116-122. May, 2004.

  53. Incidence of bipolar affective disorder in three UK cities: results from the AESOP study
    The British journal of psychiatry.: the journal of mental science, Vol. 186, No. , pp. 126-131. Feb, 2005.

  54. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42
    Molecular psychiatry., Vol. 9, No. 12, pp. 1083-1090. Dec, 2004.

  55. Brain-immune interactions and disease susceptibility
    Mol.Psychiatry, Vol. 10, No. 3, pp. 239-250. Mar, 2005.

  56. Safety considerations in pharmacotherapy of bipolar disorder
    CNS spectrums, Vol. 9, No. 11 Suppl 12, pp. 16-26. Nov, 2004.

  57. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European multicenter association study of affective disorders
    Am.J.Med.Genet.B., Vol. 114, No. 2, pp. 177-185. , 2002.

  58. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study
    Soc.Sci.Med., Vol. 60, No. 1, pp. 109-118. Jan, 2005.

  59. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study
    Soc.Sci.Med., Vol. 60, No. 1, pp. 109-118. Jan, 2005.

  60. Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene
    American journal of medical genetics, Vol. 96, No. 2, pp. 154-157. Apr 3, 2000.

  61. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder
    Neuroscience letters, Vol. 337, No. 1, pp. 17-20. Jan 30, 2003.

  62. The Brain-Derived Neurotrophic Factor Gene Confers Susceptibility to Bipolar Disorder: Evidence from a Family-Based Association Study
    Am.J.Hum.Genet., Vol. 71, No. 3, pp. 651-655. Sep, 2002.

  63. Bipolar Disorder
    , Vol. , No. , pp. 153-174. , 2003.

  64. Pharmacotherapy in the context of cognitive therapy for patients with bipolar disorder
    , Vol. , No. , pp. 101-136. , 2002.

  65. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: A Belgian patient-control study
    Am.J.Med.Genet.B., Vol. 129B, No. 1, pp. 34-35. , 2004.

  66. Genetic linkage of bipolar disorder to chromosome 6q22 is a consistent finding in Portuguese subpopulations and may generalize to broader populations
    Am.J.Med.Genet.B., Vol. 134B, No. 1, pp. 119-121. , 2005.

  67. The role of estrogen in mood disorders in women
    International review of psychiatry.(Abingdon, England), Vol. 15, No. 3, pp. 280-290. Aug, 2003.

  68. Novel aspects of signaling and ion-homeostasis regulation in immunocytes. The TRPM ion channels and their potential role in modulating the immune response
    Molecular immunology, Vol. 41, No. 6-7, pp. 657-673. Jul, 2004.

  69. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients
    Bipolar disorders, Vol. 5, No. 6, pp. 468-472. Dec, 2003.

  70. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT
    J.Neuroimmunol., Vol. 148, No. 1-2, pp. 54-62. Mar, 2004.

  71. Bipolar disorders in children and adolescents
    Journal of pediatric health.care.: official publication of National Association of Pediatric Nurse.Associates & Practitioners, Vol. 19, No. 3, pp. 131-141. May-Jun, 2005.

  72. Cognitive Therapy of Bipolar Disorder
    , Vol. , No. , pp. 228-243. , 2004.

  73. Cognitive therapy for clients with bipolar disorder
    , Vol. , No. , pp. 236-264. , 2002.

  74. A pilot study of cognitive therapy in bipolar disorders
    Psychol.Med., Vol. 31, No. 3, pp. 459-467. Apr, 2001.

  75. Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior
    Am.J.Med.Genet.B., Vol. 119B, No. 1, pp. 108-113. , 2003.

  76. Inhibition of interleukin-12 expression in diltiazem-treated dendritic cells through the reduction of nuclear factor-kappa B transcriptional activity
    Biochemical pharmacology, Vol. 69, No. 3, pp. 425-32. Epub: 2004 Dec 09. Feb 1, 2005.

  77. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females
    Psychoneuroendocrinology, Vol. 30, No. 2, pp. 162-178. Feb, 2005.

  78. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region
    American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, Vol. 135, No. 1, pp. 50-58. May 5, 2005.

  79. Genetic heterogeneity in a very large bipolar affective disorder pedigree from Quebec
    Am.J.Med.Genet.B., Vol. 119B, No. 1, pp. 65-68. , 2003.

  80. Genetic heterogeneity in a very large bipolar affective disorder pedigree from Quebec
    Am.J.Med.Genet.B., Vol. 119B, No. 1, pp. 65-68. , 2003.

  81. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder
    The world journal of biological psychiatry.: the official journal of the World Federation of Societies of Biological Psychiatry., Vol. 5, No. 4, pp. 215-220. Oct, 2004.

  82. BDNF polymorphism and association with bipolar disorder
    , Vol. , No. US Patent: 6458541, pp. . , 2002.

  83. Role of Protein Kinase C- alpha in the Control of Infection by Intracellular Pathogens in Macrophages
    J.Immunol., Vol. 163, No. 10, pp. 5505-5511. 15 Nov, 1999.

  84. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder
    American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, Vol. 131, No. 1, pp. 16-19. Nov 15, 2004.

  85. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder
    Am.J.Med.Genet.B., Vol. 131B, No. 1, pp. 16-19. , 2004.

  86. Not asleep, not quite awake
    Nat.Med., Vol. 10, No. 7, pp. 673-674. Jul, 2004.

  87. Psychiatric disorders and mutations at the Wolfram syndrome locus
    Biological psychiatry., Vol. 47, No. 9, pp. 787-793. May 1, 2000.

  88. Predisposition of Wolfram syndrome heterozygotes to psychiatric illness
    Molecular psychiatry., Vol. 3, No. 1, pp. 86-91. Jan, 1998.

  89. Psychiatric findings in Wolfram syndrome homozygotes
    Lancet, Vol. 336, No. 8716, pp. 667-669. , 1990.

  90. Is mania caused by overactivity of central brain-derived neurotrophic factor?
    Medical hypotheses, Vol. 62, No. 1, pp. 19-22. , 2004.

  91. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
    Proceedings of the National Academy of Sciences of the United.States of America, Vol. 102, No. 6, pp. 2152-7. Epub: 2005 Jan 31. Feb 8, 2005.

  92. Joint multi-population analysis for genetic linkage of bipolar disorder or "wellness" to chromosome 4p
    Am.J.Med.Genet.B., Vol. 133B, No. 1, pp. 18-24. , 2005.

  93. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains
    Biological psychiatry., Vol. 40, No. 7, pp. 568-575. Oct 1, 1996.

  94. Phenotype definitions: some hidden issues in psychiatry
    American journal of medical genetics, Vol. 105, No. 1, pp. 45-47. Jan 8, 2001.

  95. Clinical Pharmacology of MAO Inhibitors: Safety and Future
    Neurotoxicology, Vol. 25, No. 1-2, pp. 215-221. Jan, 2004.

  96. Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X
    Am.J.Med.Genet.B., Vol. 119B, No. 1, pp. 69-76. , 2003.